Send feedback

RELN p.Ser2063=

c.6189C>T · rs529198383 · VCV1108525

Conflicting classifications of pathogenicity Conflicting submitters
Classification
Conflicting classifications of pathogenicity
ClinVar
Review
Conflicting submitters ★☆☆☆
ClinVar · 3 submitters
gnomAD v4.1
Rare
ultra-rare (popmax 0.0307%, afr)
Conditions
2
Norman-Roberts syndrome

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation carries the signal.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 5.9GERP 0.013, phastCons 1
Overall
CADD8.538PHRED · no single calibrated threshold — expert panels disagree

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.0307% African / African-American · 23/74,928 alleles
Filtering AF 0.021% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.0178%
Overall 0.00173% 28/1,613,962 alleles · ultra-rare exomes 16/1,461,766 · genomes 12/152,196 · joint denominator
Ancestry group Frequency 1 in
African / African-Americangrpmax 0.0307% 3,258
Remaining individualsnot grpmax-eligible 0.008% 12,498

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
RELN
Protein
p.Ser2063=
Coding
c.6189C>T
MANE Select
NM_005045
dbSNP
rs529198383
Type
single nucleotide variant
Location
chr7:103551180 (GRCh38)
Gene constraint
LOEUF 0.276 · pLI 1.00 · ClinGen HI 0/3 (gnomAD)
Full RELN gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/reln-p-ser2063 (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown